Literature DB >> 26928581

Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD.

Silvia Morbelli1, Michela Ferrara2, Francesco Fiz3, Barbara Dessi2, Dario Arnaldi2, Agnese Picco2, Irene Bossert3, Ambra Buschiazzo3, Jennifer Accardo2, Lorena Picori3, Nicola Girtler2,4, Paola Mandich5, Marco Pagani6,7, Gianmario Sambuceti3, Flavio Nobili2.   

Abstract

PURPOSE: The diagnosis of behavioural variant frontotemporal dementia (bvFTD) is challenging during the predementia stage when symptoms are subtle and confounding. Morphological and functional neuroimaging can be particularly helpful during this stage but few data are available.
METHODS: We retrospectively selected 25 patients with late-onset probable bvFTD. Brain structural MRI and FDG PET were performed during the predementia stage (mean MMSE score 27.1 ± 2.5) on average 2 years before. The findings with the two imaging modalities were compared (SPM8) with those in a group of 20 healthy subjects. The bvFTD patients were divided into two subgroups: those with predominant disinhibition (bvFTD+) and those with apathy (bvFTD-).
RESULTS: Hypometabolism exceeded grey matter (GM) density reduction in terms of both extension and statistical significance in all comparisons. In the whole bvFTD group, hypometabolism involved the bilateral medial, inferior and superior lateral frontal cortex, anterior cingulate, left temporal and right parietal cortices and the caudate nuclei. GM density reduction was limited to the right frontal cortex and the left medial temporal lobe. In bvFTD+ patients hypometabolism was found in the bilateral medial and basal frontal cortex, while GM reduction involved the left anterior cingulate and left inferior frontal cortices, and the right insula. In bvFTD- patients, atrophy and mainly hypometabolism involved the lateral frontal cortex and the inferior parietal lobule.
CONCLUSION: These findings suggest that hypometabolism is more extensive than, and thus probably precedes, atrophy in predementia late-onset bvFTD, underscoring different topographic involvement in disinhibited and apathetic presentations. If confirmed in a larger series, these results should prompt biomarker operationalization in bvFTD, especially for patient selection in therapeutic clinical trials.

Entities:  

Keywords:  Brain PET; Frontotemporal dementia; Mild cognitive impairment

Mesh:

Substances:

Year:  2016        PMID: 26928581     DOI: 10.1007/s00259-016-3335-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  45 in total

1.  Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

Authors:  Isabelle Le Ber; Eric Guedj; Audrey Gabelle; Patrice Verpillat; Magali Volteau; Catherine Thomas-Anterion; Marielle Decousus; Didier Hannequin; Pierre Véra; Lucette Lacomblez; Agnès Camuzat; Mira Didic; Michèle Puel; Jean-Albert Lotterie; Véronique Golfier; Anne-Marie Bernard; Martine Vercelletto; Christine Magne; François Sellal; Izzie Namer; Bernard-François Michel; Jacques Pasquier; François Salachas; Jean Bochet; Alexis Brice; Marie-Odile Habert; Bruno Dubois
Journal:  Brain       Date:  2006-11       Impact factor: 13.501

2.  Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Alex Drzezga; Robert Perneczky; Giovanni B Frisoni; Anna Caroli; Bart N M van Berckel; Rik Ossenkoppele; Eric Guedj; Mira Didic; Andrea Brugnolo; Gianmario Sambuceti; Marco Pagani; Eric Salmon; Flavio Nobili
Journal:  Neurobiol Aging       Date:  2012-02-23       Impact factor: 4.673

Review 3.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

4.  Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.

Authors:  Silvia Morbelli; Arnoldo Piccardo; Giampiero Villavecchia; Barbara Dessi; Andrea Brugnolo; Alessandra Piccini; Anna Caroli; Giovanni Frisoni; Guido Rodriguez; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

5.  The heterogeneity of frontotemporal dementia with regard to initial symptoms, qEEG and neuropathology.

Authors:  Ulla Passant; Ingmar Rosén; Lars Gustafson; Elisabet Englund
Journal:  Int J Geriatr Psychiatry       Date:  2005-10       Impact factor: 3.485

6.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia.

Authors:  J S Snowden; D Bathgate; A Varma; A Blackshaw; Z C Gibbons; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

7.  Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty.

Authors:  Simon B Eickhoff; Angela R Laird; Christian Grefkes; Ling E Wang; Karl Zilles; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

8.  Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.

Authors:  Flavio Nobili; Claudio Campus; Dario Arnaldi; Fabrizio De Carli; Gaia Cabassi; Andrea Brugnolo; Barbara Dessi; Silvia Morbelli; Gianmario Sambuceti; Giovanni Abbruzzese; Guido Rodriguez
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

Review 9.  Frontotemporal dementia.

Authors:  David C Perry; Bruce L Miller
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

10.  Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale.

Authors:  Christopher M Kipps; R Rhys Davies; Joanna Mitchell; Jillian J Kril; Glenda M Halliday; John R Hodges
Journal:  Dement Geriatr Cogn Disord       Date:  2007-03-19       Impact factor: 2.959

View more
  8 in total

Review 1.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 2.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

3.  A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia.

Authors:  Amir Nazem; Chris C Tang; Phoebe Spetsieris; Christian Dresel; Marc L Gordon; Janine Diehl-Schmid; Timo Grimmer; Igor Yakushev; Paul J Mattis; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-29

4.  The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications.

Authors:  Helena Gossye; Christine Van Broeckhoven; Sebastiaan Engelborghs
Journal:  Front Neurosci       Date:  2019-08-06       Impact factor: 4.677

5.  Physiological, behavioral and subjective sadness reactivity in frontotemporal dementia subtypes.

Authors:  Alice Y Hua; Kuan-Hua Chen; Casey L Brown; Sandy J Lwi; James J Casey; Howard J Rosen; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2019-12-30       Impact factor: 3.436

Review 6.  Frontotemporal Dementia and Glucose Metabolism.

Authors:  Liam Rodney Garrett; Teresa Niccoli
Journal:  Front Neurosci       Date:  2022-02-23       Impact factor: 5.152

Review 7.  Imaging and fluid biomarkers in frontotemporal dementia.

Authors:  Lieke H Meeter; Laura Donker Kaat; Jonathan D Rohrer; John C van Swieten
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

Review 8.  Cognitive and behavioural inhibition deficits in neurodegenerative dementias.

Authors:  Raffaella Migliaccio; Delphine Tanguy; Arabella Bouzigues; Idil Sezer; Bruno Dubois; Isabelle Le Ber; Bénédicte Batrancourt; Valérie Godefroy; Richard Levy
Journal:  Cortex       Date:  2020-08-10       Impact factor: 4.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.